BRIEF-Relypsa says Phase 4 TOURMALINE study meets primary endpoint
August 30, 2016 at 16:13 PM EDT
* Announces phase 4 study shows veltassa demonstrated similar efficacy and safety whether given with or without food in patients with hyperkalemia